Intracranial FGFR3 gene fusions have been only detected in IDH wild-type diffuse gliomas [4, 6, 8, 34], suggesting that FGFR3 fusions may contribute to the characteristics of this highly aggressive and invasive type of glioma. Here, IDH2 is linked to central nervous system cancer.